Alnylam Pharmaceuticals, Inc. , the leading RNA interference (RNAi) therapeutics company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...

Often seen as an option of last resort for ventricular tachycardia, new research suggests catheter ablation could have a ...